National Comprehensive Cancer Network



About NCCN

Melanoma Panel - Disclosures as of 8/2/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Alain P Algazi, MD

         

Pending

Robert Andtbacka, MD

Amgen Inc.

Amgen Inc.;
Merck & Co., Inc.

None

None

None

4/15/2015

Christopher K. Bichakjian, MD

None

None

None

None

None

2/25/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

William E. Carson III, MD

National Cancer Institute

None

None

None

None

4/24/2015

Daniel G. Coit, MD

MSLT-II

None

None

None

None

12/9/2014

Gregory A. Daniels, MD, PhD

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.

None

None

None

None

4/7/2015

Dominick DiMaio, MD

None

None

None

None

None

3/26/2015

Anita Engh

None

None

None

None

None

3/20/2015

Fayna Ferkle, PharmD

None

None

None

None

None

4/9/2015

Ryan C. Fields, MD

Washington University

None

None

None

None

4/15/2015

Martin D. Fleming, MD, FACS

None

Amgen Inc.

None

None

None

3/10/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

6/8/2015

Rene Gonzalez, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Hana Biosciences, Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Morphotek Inc.;
Novartis Pharmaceuticals Corporation;
Castle Bioscience;
Neostem;
polynoma;
Prometheus;
Roche Laboratories, Inc.;
Takeda Pharmaceuticals North America, Inc.

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Castle Bioscience

None

None

None

6/4/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Valerie Guild

None

None

None

None

None

3/16/2015

Allan C. Halpern, MD

Janssen Research & Development, LLC;
Quintiles

Novartis Pharmaceuticals Corporation;
Caliber ID;
Canfield Scientific;
DermTech;
SciBase

None

None

None

6/16/2015

F. Stephen Hodi, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Bristol-Myers Squibb Company;
MedImmune Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
EMD Serono Merck

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

None

None

12/10/2014

Richard W. Joseph, MD

Amgen Inc.;
Genentech, Inc.;
Merck & Co., Inc.

Bristol-Myers Squibb Company;
NEKTAR Therapeutics

None

None

None

3/3/2015

Nikhil I. Khushalani, MD

AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Celgene Corporation;
Eisai Inc.;
Genentech, Inc.;
Merck & Co., Inc.;
CytRx;
NCCN (Grant funded clinical trials from the ORP);
Threshold;
Tracon;
Pfizer Inc.

Amgen Inc.;
Bristol-Myers Squibb Company

Prometheus

None

None

6/11/2015

Julie R. Lange, MD, ScM

None

None

None

None

None

3/9/2015

Mary C. Martini, MD

Derm Tech Inc

dove- unilever

Dove-Unilever

None

None

3/6/2015

Miguel A. Materin, MD

None

Back Bay Life Science Advisors;
Trial case

None

None

None

6/29/2014

Joan S. McClure, MS

None

None

None

None

None

6/18/2015

Nicole McMillian, MS

None

None

None

None

None

4/9/2015

Anthony J. Olszanski, MD

Millennium Pharmaceuticals, Inc.

Bristol-Myers Squibb Company;
Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.

None

None

None

1/27/2015

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

Merrick I. Ross, MD

None

Amgen Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Provectus Pharmaceuticals

Amgen Inc.;
Amgen Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Merck & Co., Inc.;
Provectus Pharmaceuticals

None

None

5/6/2015

April K S Salama, MD

Bristol-Myers Squibb Company;
Merck & Co., Inc.;
Reata;
Roche Laboratories, Inc.

Bristol-Myers Squibb Company

None

None

None

6/9/2015

Jeffrey A. Sosman, MD

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.

Amgen Inc.;
Genentech, Inc.

Amgen Inc.;
Genentech, Inc.

None

None

3/14/2015

Susan M. Swetter, MD

None

None

None

None

None

12/9/2014

Kenneth K. Tanabe, MD

National Cancer Institute;
NIH/NCI

Best Doctors;
CRICO;
Department of Defense, CDMRP;
LEK Consulting;
UpToDate

None

None

None

6/15/2015

John A. Thompson, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Agensys;
Altor Biosciences;
Seattle Genetics

Amgen Inc.;
Bristol-Myers Squibb Company;
Celldex

None

None

None

4/16/2015

Javier F. Torres-Roca, MD

Cvergenx, Inc

None

None

Cvergenx, Inc;
Cvergenx, Inc;
Cvergenx,Inc

None

4/28/2015

Vijay Trisal, MD

None

None

Amgen Inc.

None

None

3/23/2015

Marshall M. Urist, MD

MSLT 2 Trial

Myriad Genetic Laboratories, Inc.

None

None

None

4/29/2015